MedPath

Saturated Fatty Acids Intake and Mortality, Diabetes, Hypertension and Overweight

Completed
Conditions
Diabetes
Morality
Hypertension
Overweight
Registration Number
NCT03281512
Lead Sponsor
Zhejiang University
Brief Summary

The role of saturated fatty acids (SFAs) intake in the development of total death, cardiovascular diseases, diabetes, hypertension and overweight are in great controversy but evidence from large population in China is scant.The investigators aim to use the data from the China Health and Nutrition Survey to assess the long-term association of SFAs intake with total mortality, diabetes, hypertension and overweight.

Detailed Description

The role of saturated fatty acids (SFAs) intake in the development of total death, diabetes, hypertension and overweight are in great controversy but evidence from large population in China is lacking.The investigators aim to utilize the data from the China Health and Nutrition Survey. The investigators will calculate the cumulative average intake of SFAs based on 3 consecutive 24-h dietary recalls in each round.Sex-specific Cox regression models will be used to estimate the relative risk.Results from our work will be used to provide epidemiological evidence for improving recommendation on SFAs intake for Chinese in dietary guidelines.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14383
Inclusion Criteria
  • Adults aged ≥20 with complete data on diet and follow-up time
Exclusion Criteria
  • Cardiovascular diseases
  • Diabetes (for analyses of diabetes)
  • Body mass index ≥ 24 kg/㎡ (for analyses of overweight)
  • Hypertension (for analyses of hypertension)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
MortalityFrom baseline until death or censoring on 31 December 2011, whichever came first, assessed up to an average of 10 years

Incidence of all-cause death, on basis of household members' report

DiabetesFrom entry into the study (baseline: 1997-2009) until 2011

Incidence of diabetes, on basis of self-reported physician diagnosis, fasting plasma glucose ≥ 7.0 mmol/l or HbA1c ≥ 6.5%

Secondary Outcome Measures
NameTimeMethod
HypertensionFrom entry into the study (baseline: 1997-2009) until 2011

Incidence of hypertension, on basis of self-reported physician diagnosis, systolic pressure ≥ 140 mmHg or diastolic pressure ≥ 90 mmHg

Saturated fatty acids intakeFrom entry into the study (baseline: 1997-2009) until 2011

Cumulative average intake of saturated fatty acids on basis of 3 consecutive 24-h dietary recalls

OverweightFrom entry into the study (baseline: 1997-2009) until 2011

Incidence of overweight, on basis of body mass index (BMI), BMI ≥ 24 kg/㎡

© Copyright 2025. All Rights Reserved by MedPath